Bridget A. Tripp
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bridget A. Tripp has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Hasan H. Otu
Department of Electrical and Computer Engineering, University of Nebraska-Lincoln, Lincoln, Nebraska
3 shared publications - Amy B. Howell
Marucci Center for Blueberry and Cranberry Research, Rutgers University, Chatsworth, New Jersey, USA
2 shared publications - Connor L. Howard
Department of Surgery, Section of Thoracic Surgery, and
2 shared publications - Jennifer Clarke
Department of Food Science Technology, University of Nebraska, Lincoln, USA
2 shared publications - Katherine M. Weh
Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, United States
2 shared publications - Laura A. Kresty
Section of Thoracic Surgery, Department of Surgery, University of Michigan, Ann Arbor, USA
2 shared publications
Latest Publications
- Open Access
- 30 July 2024
- Published by MDPI AG in Biomolecules
- Vol. 14 (8) , 924
Integrated Multi-Omics Analysis of Cerebrospinal Fluid in Postoperative Delirium
Preoperative risk biomarkers for delirium may aid in identifying high-risk patients and developing intervention therapies, which would minimize the health and economic burden of postoperative delirium. Previous studies have typically used single omics approaches to identify such biomarkers. Preoperative cerebrospinal fluid (CSF) from the Healthier Postoperative Recovery study of adults ≥ 63 years old undergoing elective major orthopedic surgery was used in a matched pair delirium case–no delirium control design. We performed metabolomics and lipidomics, which were combined with our previously reported proteomics results on the same samples. Differential expression, clustering, classification, and systems biology analyses were applied to individual and combined omics datasets. Probabilistic graph models were used to identify an integrated multi-omics interaction network, which included clusters of heterogeneous omics interactions among lipids, metabolites, and proteins. The combined multi-omics signature of 25 molecules attained an AUC of 0.96 [95% CI: 0.85–1.00], showing improvement over individual omics-based classification. We conclude that multi-omics integration of preoperative CSF identifies potential risk markers for delirium and generates new insights into the complex pathways associated with delirium. With future validation, this hypotheses-generating study may serve to build robust biomarkers for delirium and improve our understanding of its pathophysiology.
- 30 July 2024
- Published by MDPI AG in Biomolecules
- Vol. 14 (8) , 924
Open AccessIntegrated Multi-Omics Analysis of Cerebrospinal Fluid in Postoperative Delirium
Preoperative risk biomarkers for delirium may aid in identifying high-risk patients and developing intervention therapies, which would minimize the health and economic burden of postoperative delirium. Previous studies have typically used single omics approaches to identify such biomarkers. Preoperative cerebrospinal fluid (CSF) from the Healthier Postoperative Recovery study of adults ≥ 63 years old undergoing elective major orthopedic surgery was used in a matched pair delirium case–no delirium control design. We performed metabolomics and lipidomics, which were combined with our previously reported proteomics results on the same samples. Differential expression, clustering, classification, and systems biology analyses were applied to individual and combined omics datasets. Probabilistic graph models were used to identify an integrated multi-omics interaction network, which included clusters of heterogeneous omics interactions among lipids, metabolites, and proteins. The combined multi-omics signature of 25 molecules attained an AUC of 0.96 [95% CI: 0.85–1.00], showing improvement over individual omics-based classification. We conclude that multi-omics integration of preoperative CSF identifies potential risk markers for delirium and generates new insights into the complex pathways associated with delirium. With future validation, this hypotheses-generating study may serve to build robust biomarkers for delirium and improve our understanding of its pathophysiology.
- Open Access
- 7 December 2023
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (12) , 1697
Cranberry Proanthocyanidins Mitigate Reflux-Induced Transporter Dysregulation in an Esophageal Adenocarcinoma Model
We recently reported that cranberry proanthocyanidins (C-PACs) inhibit esophageal adenocarcinoma (EAC) by 83% through reversing reflux-induced bacterial, inflammatory and immune-implicated proteins and genes as well as reducing esophageal bile acids, which drive EAC progression. This study investigated whether C-PACs’ mitigation of bile reflux-induced transporter dysregulation mechanistically contributes to EAC prevention. RNA was isolated from water-, C-PAC- and reflux-exposed rat esophagi with and without C-PAC treatment. Differential gene expression was determined by means of RNA sequencing and RT-PCR, followed by protein assessments. The literature, coupled with the publicly available Gene Expression Omnibus dataset GSE26886, was used to assess transporter expression levels in normal and EAC patient biopsies for translational relevance. Significant changes in ATP-binding cassette (ABC) transporters implicated in therapeutic resistance in humans (i.e., Abcb1, Abcb4, Abcc1, Abcc3, Abcc4, Abcc6 and Abcc10) and the transport of drugs, xenobiotics, lipids, and bile were altered in the reflux model with C-PACs’ mitigating changes. Additionally, C-PACs restored reflux-induced changes in solute carrier (SLC), aquaporin, proton and cation transporters (i.e., Slc2a1, Slc7a11, Slc9a1, Slco2a1 and Atp6v0c). This research supports the suggestion that transporters merit investigation not only for their roles in metabolism and therapeutic resistance, but as targets for cancer prevention and targeting preventive agents in combination with chemotherapeutics.
- 7 December 2023
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (12) , 1697
Open AccessCranberry Proanthocyanidins Mitigate Reflux-Induced Transporter Dysregulation in an Esophageal Adenocarcinoma Model
We recently reported that cranberry proanthocyanidins (C-PACs) inhibit esophageal adenocarcinoma (EAC) by 83% through reversing reflux-induced bacterial, inflammatory and immune-implicated proteins and genes as well as reducing esophageal bile acids, which drive EAC progression. This study investigated whether C-PACs’ mitigation of bile reflux-induced transporter dysregulation mechanistically contributes to EAC prevention. RNA was isolated from water-, C-PAC- and reflux-exposed rat esophagi with and without C-PAC treatment. Differential gene expression was determined by means of RNA sequencing and RT-PCR, followed by protein assessments. The literature, coupled with the publicly available Gene Expression Omnibus dataset GSE26886, was used to assess transporter expression levels in normal and EAC patient biopsies for translational relevance. Significant changes in ATP-binding cassette (ABC) transporters implicated in therapeutic resistance in humans (i.e., Abcb1, Abcb4, Abcc1, Abcc3, Abcc4, Abcc6 and Abcc10) and the transport of drugs, xenobiotics, lipids, and bile were altered in the reflux model with C-PACs’ mitigating changes. Additionally, C-PACs restored reflux-induced changes in solute carrier (SLC), aquaporin, proton and cation transporters (i.e., Slc2a1, Slc7a11, Slc9a1, Slco2a1 and Atp6v0c). This research supports the suggestion that transporters merit investigation not only for their roles in metabolism and therapeutic resistance, but as targets for cancer prevention and targeting preventive agents in combination with chemotherapeutics.
- Open Access
Prebiotic proanthocyanidins inhibit bile reflux-induced esophageal adenocarcinoma through reshaping the gut microbiome and esophageal metabolome
The gut and local esophageal microbiome progressively shift from healthy commensal bacteria to inflammatory-linked pathogenic bacteria in patients with gastroesophageal reflux disease, Barrett’s esophagus and esophageal adenocarcinoma (EAC). However, mechanisms by which microbial communities and metabolites contribute to reflux-driven EAC remain incompletely understood and challenging to target. Herein, we utilized a rat reflux-induced EAC model to investigate targeting the gut microbiome-esophageal metabolome axis with cranberry proanthocyanidins (C-PAC) to inhibit EAC progression. Sprague Dawley rats, with or without reflux-induction received water or C-PAC ad libitum (700 µg/rat/day) for 25 or 40 weeks. C-PAC exerted prebiotic activity abrogating reflux-induced dysbiosis, and mitigating bile acid metabolism and transport, culminating in significant inhibition of EAC through TLR/NF-κB/P53 signaling cascades. At the species level, C-PAC mitigated reflux-induced pathogenic bacteria (Clostridium perfringens, Escherichia coli, and Proteus mirabilis). C-PAC specifically reversed reflux-induced bacterial, inflammatory and immune-implicated proteins and genes including Ccl4, Cd14, Crp, Cxcl1, Il6, Il1β, Lbp, Lcn2, Myd88, Nfkb1, Tlr2 and Tlr4 aligning with changes in human EAC progression, as confirmed through public databases. C-PAC is a safe promising dietary constituent that may be utilized alone or potentially as an adjuvant to current therapies to prevent EAC progression through ameliorating reflux-induced dysbiosis, inflammation and cellular damage.
Open AccessPrebiotic proanthocyanidins inhibit bile reflux-induced esophageal adenocarcinoma through reshaping the gut microbiome and esophageal metabolome
The gut and local esophageal microbiome progressively shift from healthy commensal bacteria to inflammatory-linked pathogenic bacteria in patients with gastroesophageal reflux disease, Barrett’s esophagus and esophageal adenocarcinoma (EAC). However, mechanisms by which microbial communities and metabolites contribute to reflux-driven EAC remain incompletely understood and challenging to target. Herein, we utilized a rat reflux-induced EAC model to investigate targeting the gut microbiome-esophageal metabolome axis with cranberry proanthocyanidins (C-PAC) to inhibit EAC progression. Sprague Dawley rats, with or without reflux-induction received water or C-PAC ad libitum (700 µg/rat/day) for 25 or 40 weeks. C-PAC exerted prebiotic activity abrogating reflux-induced dysbiosis, and mitigating bile acid metabolism and transport, culminating in significant inhibition of EAC through TLR/NF-κB/P53 signaling cascades. At the species level, C-PAC mitigated reflux-induced pathogenic bacteria (Clostridium perfringens, Escherichia coli, and Proteus mirabilis). C-PAC specifically reversed reflux-induced bacterial, inflammatory and immune-implicated proteins and genes including Ccl4, Cd14, Crp, Cxcl1, Il6, Il1β, Lbp, Lcn2, Myd88, Nfkb1, Tlr2 and Tlr4 aligning with changes in human EAC progression, as confirmed through public databases. C-PAC is a safe promising dietary constituent that may be utilized alone or potentially as an adjuvant to current therapies to prevent EAC progression through ameliorating reflux-induced dysbiosis, inflammation and cellular damage.
- Open Access
Multiomics Approach Captures Hepatic Metabolic Network Altered by Chronic Ethanol Administration
Using a multiplatform and multiomics approach, we identified metabolites, lipids, proteins, and metabolic pathways that were altered in the liver after chronic ethanol administration. A functional enrichment analysis of the multiomics dataset revealed that rats treated with ethanol experienced an increase in hepatic fatty acyl content, which is consistent with an initial development of steatosis. The nuclear magnetic resonance spectroscopy (NMR) and liquid chromatography–mass spectrometry (LC-MS) metabolomics data revealed that the chronic ethanol exposure selectively modified toxic substances such as an increase in glucuronidation tyramine and benzoyl; and a depletion in cholesterol-conjugated glucuronides. Similarly, the lipidomics results revealed that ethanol decreased diacylglycerol, and increased triacylglycerol, sterol, and cholesterol biosynthesis. An integrated metabolomics and lipidomics pathway analysis showed that the accumulation of hepatic lipids occurred by ethanol modulation of the upstream lipid regulatory pathways, specifically glycolysis and glucuronides pathways. A proteomics analysis of lipid droplets isolated from control EtOH-fed rats and a subsequent functional enrichment analysis revealed that the proteomics data corroborated the metabolomic and lipidomic findings that chronic ethanol administration altered the glucuronidation pathway.
Open AccessMultiomics Approach Captures Hepatic Metabolic Network Altered by Chronic Ethanol Administration
Using a multiplatform and multiomics approach, we identified metabolites, lipids, proteins, and metabolic pathways that were altered in the liver after chronic ethanol administration. A functional enrichment analysis of the multiomics dataset revealed that rats treated with ethanol experienced an increase in hepatic fatty acyl content, which is consistent with an initial development of steatosis. The nuclear magnetic resonance spectroscopy (NMR) and liquid chromatography–mass spectrometry (LC-MS) metabolomics data revealed that the chronic ethanol exposure selectively modified toxic substances such as an increase in glucuronidation tyramine and benzoyl; and a depletion in cholesterol-conjugated glucuronides. Similarly, the lipidomics results revealed that ethanol decreased diacylglycerol, and increased triacylglycerol, sterol, and cholesterol biosynthesis. An integrated metabolomics and lipidomics pathway analysis showed that the accumulation of hepatic lipids occurred by ethanol modulation of the upstream lipid regulatory pathways, specifically glycolysis and glucuronides pathways. A proteomics analysis of lipid droplets isolated from control EtOH-fed rats and a subsequent functional enrichment analysis revealed that the proteomics data corroborated the metabolomic and lipidomic findings that chronic ethanol administration altered the glucuronidation pathway.
- 1 January 2022
- Published by Bentham Science Publishers Ltd. in Current Bioinformatics
- Vol. 17 (1) , 37-47
Integration of Multi-Omics Data Using Probabilistic Graph Models and External Knowledge
Background: High-throughput sequencing technologies have revolutionized the ability to perform systems-level biology and elucidate molecular mechanisms of disease through the comprehensive characterization of different layers of biological information. Integration of these heterogeneous layers can provide insight into the underlying biology but is challenged by modeling complex interactions. Objective: We introduce OBaNK: omics integration using Bayesian networks and external knowledge, an algorithm to model interactions between heterogeneous high-dimensional biological data to elucidate complex functional clusters and emergent relationships associated with an observed phenotype. Method: Using Bayesian network learning, we modeled the statistical dependencies and interactions between lipidomics, proteomics, and metabolomics data. The strength of a learned interaction between molecules was altered based on external knowledge. Results: Networks learned from synthetic datasets based on real pathways achieved an average area under the curve score of ~0.85, an improvement of ~0.23 from baseline methods. When applied to real multi-omics data collected during pregnancy, five distinct functional networks of heterogeneous biological data were identified, and the results were compared to other multi-omics integration approaches. Conclusion: OBaNK successfully improved the accuracy of learning interaction networks from data integrating external knowledge, identified heterogeneous functional networks from real data, and suggested potential novel interactions associated with the phenotype. These findings can guide future hypothesis generation. OBaNK source code is available at https://github.com/bridgettripp/OBaNK.git, and a graphical user interface is available at http://otulab.unl.edu/OBaNK.
- 1 January 2022
- Published by Bentham Science Publishers Ltd. in Current Bioinformatics
- Vol. 17 (1) , 37-47
Integration of Multi-Omics Data Using Probabilistic Graph Models and External Knowledge
Background: High-throughput sequencing technologies have revolutionized the ability to perform systems-level biology and elucidate molecular mechanisms of disease through the comprehensive characterization of different layers of biological information. Integration of these heterogeneous layers can provide insight into the underlying biology but is challenged by modeling complex interactions. Objective: We introduce OBaNK: omics integration using Bayesian networks and external knowledge, an algorithm to model interactions between heterogeneous high-dimensional biological data to elucidate complex functional clusters and emergent relationships associated with an observed phenotype. Method: Using Bayesian network learning, we modeled the statistical dependencies and interactions between lipidomics, proteomics, and metabolomics data. The strength of a learned interaction between molecules was altered based on external knowledge. Results: Networks learned from synthetic datasets based on real pathways achieved an average area under the curve score of ~0.85, an improvement of ~0.23 from baseline methods. When applied to real multi-omics data collected during pregnancy, five distinct functional networks of heterogeneous biological data were identified, and the results were compared to other multi-omics integration approaches. Conclusion: OBaNK successfully improved the accuracy of learning interaction networks from data integrating external knowledge, identified heterogeneous functional networks from real data, and suggested potential novel interactions associated with the phenotype. These findings can guide future hypothesis generation. OBaNK source code is available at https://github.com/bridgettripp/OBaNK.git, and a graphical user interface is available at http://otulab.unl.edu/OBaNK.
- Open Access
- 15 January 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-13
Targeted metabolomics analysis of postoperative delirium
Postoperative delirium is the most common complication among older adults undergoing major surgery. The pathophysiology of delirium is poorly understood, and no blood-based, predictive markers are available. We characterized the plasma metabolome of 52 delirium cases and 52 matched controls from the Successful Aging after Elective Surgery (SAGES) cohort (N = 560) of patients ≥ 70 years old without dementia undergoing scheduled major non-cardiac surgery. We applied targeted mass spectrometry with internal standards and pooled controls using a nested matched case-control study preoperatively (PREOP) and on postoperative day 2 (POD2) to identify potential delirium risk and disease markers. Univariate analyses identified 37 PREOP and 53 POD2 metabolites associated with delirium and multivariate analyses achieved significant separation between the two groups with an 11-metabolite prediction model at PREOP (AUC = 83.80%). Systems biology analysis using the metabolites with differential concentrations rendered “valine, leucine, and isoleucine biosynthesis” at PREOP and “citrate cycle” at POD2 as the most significantly enriched pathways (false discovery rate < 0.05). Perturbations in energy metabolism and amino acid synthesis pathways may be associated with postoperative delirium and suggest potential mechanisms for delirium pathogenesis. Our results could lead to the development of a metabolomic delirium predictor.
- 15 January 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-13
Open AccessTargeted metabolomics analysis of postoperative delirium
Postoperative delirium is the most common complication among older adults undergoing major surgery. The pathophysiology of delirium is poorly understood, and no blood-based, predictive markers are available. We characterized the plasma metabolome of 52 delirium cases and 52 matched controls from the Successful Aging after Elective Surgery (SAGES) cohort (N = 560) of patients ≥ 70 years old without dementia undergoing scheduled major non-cardiac surgery. We applied targeted mass spectrometry with internal standards and pooled controls using a nested matched case-control study preoperatively (PREOP) and on postoperative day 2 (POD2) to identify potential delirium risk and disease markers. Univariate analyses identified 37 PREOP and 53 POD2 metabolites associated with delirium and multivariate analyses achieved significant separation between the two groups with an 11-metabolite prediction model at PREOP (AUC = 83.80%). Systems biology analysis using the metabolites with differential concentrations rendered “valine, leucine, and isoleucine biosynthesis” at PREOP and “citrate cycle” at POD2 as the most significantly enriched pathways (false discovery rate < 0.05). Perturbations in energy metabolism and amino acid synthesis pathways may be associated with postoperative delirium and suggest potential mechanisms for delirium pathogenesis. Our results could lead to the development of a metabolomic delirium predictor.
- 26 March 2019
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 273 (4) , 732-742
Identification of Plasma Proteome Signatures Associated With Surgery Using SOMAscan
Objectives: To characterize the proteomic signature of surgery in older adults and association with postoperative outcomes. Summary of Background Data: Circulating plasma proteins can reflect the physiological response to and clinical outcomes after surgery. Methods: Blood plasma from older adults undergoing elective surgery was analyzed for 1305 proteins using SOMAscan. Surgery-associated proteins underwent Ingenuity Pathways Analysis. Selected surgery-associated proteins were independently validated using Luminex or enzyme-linked immunosorbent assay methods. Generalized linear models estimated correlations with postoperative outcomes. Results: Plasma from a subcohort (n = 36) of the Successful Aging after Elective Surgery (SAGES) study was used for SOMAscan. Systems biology analysis of 110 proteins with Benjamini-Hochberg (BH) corrected P value ≤0.01 and an absolute foldchange (|FC|) ≥1.5 between postoperative day 2 (POD2) and preoperative (PREOP) identified functional pathways with major effects on pro-inflammatory proteins. Chitinase-3-like protein 1 (CHI3L1), C-reactive protein (CRP), and interleukin-6 (IL-6) were independently validated in separate validation cohorts from SAGES (n = 150 for CRP, IL-6; n = 126 for CHI3L1). Foldchange CHI3L1 and IL-6 were associated with increased postoperative complications [relative risk (RR) 1.50, 95% confidence interval (95% CI) 1.21–1.85 and RR 1.63, 95% CI 1.18–2.26, respectively], length of stay (RR 1.35, 95% CI 0.77–1.92 and RR 0.98, 95% CI 0.52–1.45), and risk of discharge to postacute facility (RR 1.15, 95% CI 1.04–1.26 and RR 1.11, 95% CI 1.04–1.18); POD2 and PREOP CRP difference was associated with discharge to postacute facility (RR 1.14, 95% CI 1.04–1.25). Conclusion: SOMAscan can identify novel and clinically relevant surgery-induced protein changes. Ultimately, proteomics may provide insights about pathways by which surgical stress contributes to postoperative outcomes.
- 26 March 2019
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 273 (4) , 732-742
Identification of Plasma Proteome Signatures Associated With Surgery Using SOMAscan
Objectives: To characterize the proteomic signature of surgery in older adults and association with postoperative outcomes. Summary of Background Data: Circulating plasma proteins can reflect the physiological response to and clinical outcomes after surgery. Methods: Blood plasma from older adults undergoing elective surgery was analyzed for 1305 proteins using SOMAscan. Surgery-associated proteins underwent Ingenuity Pathways Analysis. Selected surgery-associated proteins were independently validated using Luminex or enzyme-linked immunosorbent assay methods. Generalized linear models estimated correlations with postoperative outcomes. Results: Plasma from a subcohort (n = 36) of the Successful Aging after Elective Surgery (SAGES) study was used for SOMAscan. Systems biology analysis of 110 proteins with Benjamini-Hochberg (BH) corrected P value ≤0.01 and an absolute foldchange (|FC|) ≥1.5 between postoperative day 2 (POD2) and preoperative (PREOP) identified functional pathways with major effects on pro-inflammatory proteins. Chitinase-3-like protein 1 (CHI3L1), C-reactive protein (CRP), and interleukin-6 (IL-6) were independently validated in separate validation cohorts from SAGES (n = 150 for CRP, IL-6; n = 126 for CHI3L1). Foldchange CHI3L1 and IL-6 were associated with increased postoperative complications [relative risk (RR) 1.50, 95% confidence interval (95% CI) 1.21–1.85 and RR 1.63, 95% CI 1.18–2.26, respectively], length of stay (RR 1.35, 95% CI 0.77–1.92 and RR 0.98, 95% CI 0.52–1.45), and risk of discharge to postacute facility (RR 1.15, 95% CI 1.04–1.26 and RR 1.11, 95% CI 1.04–1.18); POD2 and PREOP CRP difference was associated with discharge to postacute facility (RR 1.14, 95% CI 1.04–1.25). Conclusion: SOMAscan can identify novel and clinically relevant surgery-induced protein changes. Ultimately, proteomics may provide insights about pathways by which surgical stress contributes to postoperative outcomes.
- Open Access
Phosphate starvation induces replacement of phospholipids with the betaine lipid diacylglycerol-N,N,N-trimethylhomoserine in the human fungal pathogen Candida albicans
We have previously demonstrated that phosphate starvation induces replacement of phosphatidylcholine with the betaine lipid diacylglyceryl- N , N , N -trimethylhomoserine (DGTS) in fungi. In Neurospora crassa , the BTA1 gene encodes the betaine lipid synthase, which is necessary and sufficient for DGTS synthesis. BTA1 expression and DGTS accumulation are part of the fungal phosphorus (P i ) deprivation (PHO) regulon, mediated by the NUC-1/Pho4p transcription factor. We now demonstrate that the human pathogen Candida albicans encodes a BTA1 ortholog ( Ca BTA1), which is activated during P i scarcity. The Ca BTA1 gene is also induced under certain biofilm-promoting conditions independent of P i starvation. RNA-seq and qRT-PCR showed a significant increase in Ca BTA1 expression in response to P i limitation. Thin-layer chromatography and LC-ESI-MS/MS confirmed the replacement of PC with DGTS in wild-type under low P i and showed the absence of DGTS in the bta1ΔΔ mutant. P i limitation in the gut of critically ill patients also triggers the switching of C. albicans into an invasive filamentous form. To assess the role of BTA1 and DGTS in the pathogenicity of C. albicans in vitro , we compared the growth and morphology of bta1ΔΔ and wild type in hyphaeinducing media and observed defects in biofilm formation and invasive growth in the bta1ΔΔ mutant. This observation is complemented by RNA-seq data demonstrating that P i starvation in planktonic C. albicans cells induces the expression of virulence-associated cell surface proteins. Taken together, these results show novel functional interactions between lipid metabolism and remodeling, biofilm formation, and the phosphate starvation response of C. albicans .
Open AccessPhosphate starvation induces replacement of phospholipids with the betaine lipid diacylglycerol-N,N,N-trimethylhomoserine in the human fungal pathogen Candida albicans
We have previously demonstrated that phosphate starvation induces replacement of phosphatidylcholine with the betaine lipid diacylglyceryl- N , N , N -trimethylhomoserine (DGTS) in fungi. In Neurospora crassa , the BTA1 gene encodes the betaine lipid synthase, which is necessary and sufficient for DGTS synthesis. BTA1 expression and DGTS accumulation are part of the fungal phosphorus (P i ) deprivation (PHO) regulon, mediated by the NUC-1/Pho4p transcription factor. We now demonstrate that the human pathogen Candida albicans encodes a BTA1 ortholog ( Ca BTA1), which is activated during P i scarcity. The Ca BTA1 gene is also induced under certain biofilm-promoting conditions independent of P i starvation. RNA-seq and qRT-PCR showed a significant increase in Ca BTA1 expression in response to P i limitation. Thin-layer chromatography and LC-ESI-MS/MS confirmed the replacement of PC with DGTS in wild-type under low P i and showed the absence of DGTS in the bta1ΔΔ mutant. P i limitation in the gut of critically ill patients also triggers the switching of C. albicans into an invasive filamentous form. To assess the role of BTA1 and DGTS in the pathogenicity of C. albicans in vitro , we compared the growth and morphology of bta1ΔΔ and wild type in hyphaeinducing media and observed defects in biofilm formation and invasive growth in the bta1ΔΔ mutant. This observation is complemented by RNA-seq data demonstrating that P i starvation in planktonic C. albicans cells induces the expression of virulence-associated cell surface proteins. Taken together, these results show novel functional interactions between lipid metabolism and remodeling, biofilm formation, and the phosphate starvation response of C. albicans .
- 1 July 2017
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 77 (13_Supplem) , 5250
Abstract 5250: Cranberry proanthocyanidins reverse microbial dysbiosis and inhibit bile acid metabolism in association with esophageal cancer prevention
Our laboratory has been investigating the cancer inhibitory potential of cranberry proanthocyanidins (C-PAC) against esophageal adenocarcinoma (EAC), a cancer characterized by rapidly rising incident rates and poor survival (18% 5-year survival rate for all stages combined). Utilizing a panel of validated human esophageal cancer cell lines and OE19 xenograft bearing mice, our laboratory reported that C-PAC activates autophagic cell machinery leading to caspase-independent cancer cell death, yet linked to bile acid sensitivity. Reflux of bile and stomach acid into the lower esophagus is considered the major risk factor for progression to EAC. Building on our initial research, we next investigated mechanisms by which C-PAC inhibits reflux-induced EAC with a focus on gut microbiome alterations and modulation of bile acid metabolites. Bile acids undergo secondary metabolism in the intestinal tract, but have not been evaluated in this context. We utilized the rat surgical esophagogastroduodenal anastomosis (EGDA) model for reflux-induced EAC. EGDA+ and non-surgical Sprague Dawley rats were treated with water or C-PAC (650 µg/rat/day) for 25 or 40 weeks and assessed for cancer progression via extensive histopathological characterization. Additionally, at 40 weeks, fecal microbiome profiling was investigated and metabolic profiling conducted on esophageal, liver and fecal samples. Methods included 16s rRNA sequencing of rat fecal DNA, paired end sequencing on Illumina MiSeq and data analysis using Qiime and the R packages phyloseq, and edgeR to assess C-PAC-induced microbiome changes. For metabolite profiling homogenized esophagi, liver and fecal samples were extracted in methanol and characterized by Reverse Phase Ultra high Performance Liquid Chromatography-Tandem Mass Spectrometry RP/UPLC-MS/MS, followed by metabolite identification based on Metabolon’s library of authenticated standards. Study results support that C-PAC significantly inhibits the formation of EAC with concomitant restoration of the gut microbial profile, i.e., the bacterial profile shifted toward increased favorable Gram+ Firmicutes and away from inflammatory-linked Gram negative Bacteroidetes. In addition, C-PAC treatment significantly reduced primary and secondary bile acid metabolite levels in the esophagus of reflux/EGDA+ rats. Other metabolites significantly reduced by C-PAC included a number of pro-inflammatory Eicosanoids. In summary, these results support that (1) reflux-induced microbial impairment correlates with the stimulation of bile acid metabolism, and (2) C-PAC mitigates reflux-induced inflammation and injury in the esophagus in association with EAC inhibition. Future research with C-PAC in patients with gastroesophageal reflux disease should include assessments of bile acid metabolites and bacterial profiles as potential cancer-inhibitory mechanisms. Citation Format: Katherine M. Weh, Nita H. Salzman, Amy B. Howell, Jennifer L. Clarke, Bridget A. Tripp, Laura A. Kresty. Cranberry proanthocyanidins reverse microbial dysbiosis and inhibit bile acid metabolism in association with esophageal cancer prevention [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 5250. doi:10.1158/1538-7445.AM2017-5250
- 1 July 2017
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 77 (13_Supplem) , 5250
Abstract 5250: Cranberry proanthocyanidins reverse microbial dysbiosis and inhibit bile acid metabolism in association with esophageal cancer prevention
Our laboratory has been investigating the cancer inhibitory potential of cranberry proanthocyanidins (C-PAC) against esophageal adenocarcinoma (EAC), a cancer characterized by rapidly rising incident rates and poor survival (18% 5-year survival rate for all stages combined). Utilizing a panel of validated human esophageal cancer cell lines and OE19 xenograft bearing mice, our laboratory reported that C-PAC activates autophagic cell machinery leading to caspase-independent cancer cell death, yet linked to bile acid sensitivity. Reflux of bile and stomach acid into the lower esophagus is considered the major risk factor for progression to EAC. Building on our initial research, we next investigated mechanisms by which C-PAC inhibits reflux-induced EAC with a focus on gut microbiome alterations and modulation of bile acid metabolites. Bile acids undergo secondary metabolism in the intestinal tract, but have not been evaluated in this context. We utilized the rat surgical esophagogastroduodenal anastomosis (EGDA) model for reflux-induced EAC. EGDA+ and non-surgical Sprague Dawley rats were treated with water or C-PAC (650 µg/rat/day) for 25 or 40 weeks and assessed for cancer progression via extensive histopathological characterization. Additionally, at 40 weeks, fecal microbiome profiling was investigated and metabolic profiling conducted on esophageal, liver and fecal samples. Methods included 16s rRNA sequencing of rat fecal DNA, paired end sequencing on Illumina MiSeq and data analysis using Qiime and the R packages phyloseq, and edgeR to assess C-PAC-induced microbiome changes. For metabolite profiling homogenized esophagi, liver and fecal samples were extracted in methanol and characterized by Reverse Phase Ultra high Performance Liquid Chromatography-Tandem Mass Spectrometry RP/UPLC-MS/MS, followed by metabolite identification based on Metabolon’s library of authenticated standards. Study results support that C-PAC significantly inhibits the formation of EAC with concomitant restoration of the gut microbial profile, i.e., the bacterial profile shifted toward increased favorable Gram+ Firmicutes and away from inflammatory-linked Gram negative Bacteroidetes. In addition, C-PAC treatment significantly reduced primary and secondary bile acid metabolite levels in the esophagus of reflux/EGDA+ rats. Other metabolites significantly reduced by C-PAC included a number of pro-inflammatory Eicosanoids. In summary, these results support that (1) reflux-induced microbial impairment correlates with the stimulation of bile acid metabolism, and (2) C-PAC mitigates reflux-induced inflammation and injury in the esophagus in association with EAC inhibition. Future research with C-PAC in patients with gastroesophageal reflux disease should include assessments of bile acid metabolites and bacterial profiles as potential cancer-inhibitory mechanisms. Citation Format: Katherine M. Weh, Nita H. Salzman, Amy B. Howell, Jennifer L. Clarke, Bridget A. Tripp, Laura A. Kresty. Cranberry proanthocyanidins reverse microbial dysbiosis and inhibit bile acid metabolism in association with esophageal cancer prevention [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 5250. doi:10.1158/1538-7445.AM2017-5250